AAP Revises Childhood UTI Guidelines for First Time Since 2011, Favoring Shorter Antibiotic Courses

The American Academy of Pediatrics has revised its guidance on diagnosing and treating urinary tract infections in young children, the first update to the recommendations in fifteen years. The new clinical practice guideline, published in Pediatrics, widens the age range it covers, sets a 72-hour window for testing feverish infants and toddlers, and endorses shorter courses of antibiotics than doctors have traditionally prescribed.

The guideline, issued by the American Academy of Pediatrics, replaces a 2011 standard that applied only to children ages 2 months to 2 years. The updated version extends coverage down to infants as young as 8 days old and up through age 5, reflecting what the group's guideline committee described as a more complete picture of how the infections present across early childhood.

The numbers

Urinary tract infections remain among the most common bacterial infections of infancy and early childhood. By age 6, the academy says, as many as 7 percent of girls and 2 percent of boys will have had at least one, and roughly 30 percent of children who do will have a repeat infection. The new guideline recommends that any child between 2 months and 5 years old with an unexplained fever be tested for a urinary tract infection within 72 hours.

On treatment, the guideline moves toward shorter courses: most children should receive no more than seven days of antibiotics, down from longer regimens that were common under the old framework, and children age 2 or older who are otherwise at low risk may need as few as three to five days. Oral antibiotics are now recommended over intravenous treatment and hospitalization for most children older than 28 days, a change aimed at keeping more families out of the hospital for an infection that, caught early, is usually straightforward to treat. For infections that are harder to treat, for infants, or for children judged to be at higher risk, the guideline allows for longer courses.

How the guidance got here

The 2011 guideline was itself a departure from decades of more aggressive practice, built around the idea that not every feverish infant needed extensive testing and imaging. But it was narrow in scope, covering only toddlers between 2 months and 2 years old, and left pediatricians short of clear direction for newborns and older preschoolers who turned out to have the same infections. In the years since, primary care doctors, emergency physicians and pediatric nephrologists have published a large body of research on how urinary tract infections present in those excluded age groups, on the comparative effectiveness of oral versus intravenous antibiotics, and on how long a course of treatment actually needs to be to clear the infection without encouraging antibiotic resistance.

That evidence is laid out in a companion technical report reviewing the underlying research, published alongside the new guideline in the same issue of Pediatrics. The academy's original 2011 recommendations had already been credited with reducing unnecessary imaging and hospital admissions for toddlers; the new version extends that approach to a wider age range while also responding to broader public health pressure to curb antibiotic overuse in children, a priority shared across pediatric specialties as resistant bacterial strains have become more common in community settings.

Who is affected

The guideline is aimed squarely at primary care pediatricians, family physicians and emergency department staff, who will be expected to use it as the basis for how they evaluate feverish infants and young children going forward. Because urinary tract infections are a routine reason for pediatric office and urgent care visits, the practical effect reaches a large share of American families: parents of infants younger than 2 months, previously outside the guideline's scope entirely, now have explicit direction for their children for the first time, and parents of preschoolers age 2 to 5 gain guidance where none existed before.

Shorter antibiotic courses and a preference for oral treatment over hospitalization could also mean fewer missed days of work for parents and lower costs for families and insurers, though the guideline's authors frame the changes primarily in clinical terms: matching treatment intensity to a child's actual risk, rather than defaulting to the most cautious option for every case.

What pediatricians are saying

Dr. Brian Alverson, who chaired the subcommittee that wrote the guideline, said the update reflects both the frequency of the infections and the diagnostic uncertainty that has long surrounded them in young children, who often cannot describe their symptoms.

"UTIs are one of the most common bacterial infections in infants and young children, but reaching a diagnosis can be challenging."

Dr. David Hains, the subcommittee's vice chair, framed the new recommendations as a floor rather than a rigid script, noting that the guideline is meant to work alongside, not replace, a pediatrician's judgment about an individual child. "We recognize that physicians must make decisions based on the unique needs and symptoms of each individual patient," he said. The emphasis on individualized decision-making runs through the document's approach to both testing and treatment duration, which vary depending on a child's age, risk factors and response to initial therapy rather than applying a single rule to every patient.

What happens next

The guideline's release was timed ahead of the academy's National Conference and Exhibition, which opens Friday in San Diego and includes a dedicated session for pediatricians on translating the new recommendations into daily practice. Hospital systems and pediatric practices typically use such sessions, along with accompanying continuing-education materials, to revise their own internal protocols and electronic health record order sets in the months that follow a guideline update.

Because the previous version remained in place for fifteen years, pediatric infectious disease specialists expect the revised guidance to shape how urinary tract infections in young children are diagnosed and treated well into the next decade. The companion technical report leaves open several areas, including long-term imaging strategies for children with repeat infections, that the academy says will continue to be studied as more data accumulate on the youngest patients newly brought under the guideline's scope.